1642-84-8

Upstream product

• 3228-01-1 3-methyl-2-isopropyl-phenol 
• 77-78-1 dimethyl sulfate 
• 79383-45-2 2-(2-methoxy-6-methylphenyl)-2-propanol 

Downstream Products

• 1680-82-6 1-(3-Isopropyl-4-methoxy-2-methyl-phenyl)-ethan-1-on 
• 78347-91-8 4-bromo-2-iso-propyl-3-methylanisole 
• 3752-30-5 (+/-)-3-(4-Acetyl-2-isopropyl-3-methyl-phenoxy)-butan-2-on 
• 2086-46-6 (+/-)-3-<4-Ethyl-2-isopropyl-3-methyl-phenoxy>-butan-2-on 
• 1634-58-8 1-(4-Hydroxy-3-isopropyl-2-methyl-phenyl)-ethan-1-on 
• 1634-57-7 4-Ethyl-2-isopropyl-3-methyl-anisol 
• 1634-56-6 4-Ethyl-2-isopropyl-3-methyl-phenol 

Relevant academic research and scientific papers

Novel Phosphinic Acid-Containing Thyromimetics

The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome x and diabetes.

NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS

The present invention relates to compounds of phosphonic acid containing T3 mimetics, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndromex and diabetes.